UBS LIMITED – Trademark Portfolio

Entity Type: 99

UBS LIMITED holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 4 filings in this category. The portfolio also extends into Class 2 (Paints) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include CORAX, NIPEX, ECORAX, HIBLACK, and PRINTEX. The owner is based in LONDON.

1 FINSBURY AVENUE

LONDON EC2M 2PP , GB

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

NIPEX
NIPEX
Registered 2002
HIBLACK
HIBLACK
Registered 2000
ECORAX
ECORAX
Registered 1997
CORAX
CORAX
Registered 1990
PRINTEX
PRINTEX
Registered 1971

Trademark Classifications

UBS LIMITED's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (4 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

2
Paints (3 filings)

Paints, varnishes, lacquers; preservatives against rust and against deterioration of wood

Frequently Asked Questions

How many trademarks does UBS LIMITED have?

UBS LIMITED has 6 U.S. trademarks filed with the USPTO. Of these, 6 registered.

What trademark classes does UBS LIMITED file in?

UBS LIMITED files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 2 (Paints). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are UBS LIMITED's most well-known trademarks?

UBS LIMITED's registered trademark portfolio includes well-known marks such as CORAX, NIPEX, ECORAX, HIBLACK, and PRINTEX. These are among 6 currently registered trademarks in the portfolio.

What is UBS LIMITED's trademark registration success rate?

UBS LIMITED has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.